Guidelines issued for vaccination in patients with rheumatic, musculoskeletal diseases

In new guidelines issued by the American College of Rheumatology, evidence-based recommendations are presented for the use of vaccinations in children and adults with rheumatic and musculoskeletal dis

Updated on: June 15,2024 4

Guidelines issued for vaccination in patients with rheumatic, musculoskeletal diseases

In new guidelines issued by the American College of Rheumatology, evidence-based recommendations are presented for the use of vaccinations in children and adults with rheumatic and musculoskeletal dis

Updated on:June 15,2024 4

Antibacterial material restores the efficacy of antibiotics against resistant bacteria

byChalmers University of TechnologyThe antibacterial material is a proprietary hydrogel, which can be adapted to many medical applications. Credit: Saba AtefyektaResearch from Chalmers Universit

Updated on: November 21,2024 0

Antibacterial material restores the efficacy of antibiotics against resistant bacteria

byChalmers University of TechnologyThe antibacterial material is a proprietary hydrogel, which can be adapted to many medical applications. Credit: Saba AtefyektaResearch from Chalmers Universit

Updated on:November 21,2024 0

New drug expands treatment opportunities for rheumatoid arthritis

by Medical University of ViennaCredit: Unsplash/CC0 Public DomainIn its final Phase III clinical trial, a new drug for treating rheumatoid arthritis has proved to be at least as effective as the

Updated on: June 26,2024 8

New drug expands treatment opportunities for rheumatoid arthritis

by Medical University of ViennaCredit: Unsplash/CC0 Public DomainIn its final Phase III clinical trial, a new drug for treating rheumatoid arthritis has proved to be at least as effective as the

Updated on:June 26,2024 8

Moderna and Pfizer-BioNTech vaccines prime T cells to fight SARS-CoV-2 variants

by La Jolla Institute for ImmunologyT cells from people who have recovered from COVID-19 or received the Moderna or Pfizer-BioNTech vaccines are still able to recognize several concerning SARS-Co

Updated on: April 20,2024 20

Moderna and Pfizer-BioNTech vaccines prime T cells to fight SARS-CoV-2 variants

by La Jolla Institute for ImmunologyT cells from people who have recovered from COVID-19 or received the Moderna or Pfizer-BioNTech vaccines are still able to recognize several concerning SARS-Co

Updated on:April 20,2024 20

Patients with rheumatic and musculoskeletal conditions vulnerable to long term opioid use

by British Medical JournalCredit: Unsplash/CC0 Public DomainPatients with rheumatic and musculoskeletal conditions are vulnerable to long term opioid use, with up to 1 in 3 of those with rheumato

Updated on: June 15,2024 5

Patients with rheumatic and musculoskeletal conditions vulnerable to long term opioid use

by British Medical JournalCredit: Unsplash/CC0 Public DomainPatients with rheumatic and musculoskeletal conditions are vulnerable to long term opioid use, with up to 1 in 3 of those with rheumato

Updated on:June 15,2024 5

Unusual type of antibody shows ultrapotent activity against Zika

by Weill Cornell Medical CollegeZika virus particles (red) shown in African green monkey kidney cells. Credit: NIAIDAn unusual type of antibody that even at miniscule levels neutralizes the Zika

Updated on: May 07,2024 12

Unusual type of antibody shows ultrapotent activity against Zika

by Weill Cornell Medical CollegeZika virus particles (red) shown in African green monkey kidney cells. Credit: NIAIDAn unusual type of antibody that even at miniscule levels neutralizes the Zika

Updated on:May 07,2024 12

Black patients with RA less likely to receive biologics, more likely to get glucocorticoids

by American College of RheumatologyCredit: CC0 Public DomainA new study reveals that Black patients with rheumatoid arthritis (RA) were less likely to be prescribed a biologic treatment and more

Updated on: July 02,2024 4

Black patients with RA less likely to receive biologics, more likely to get glucocorticoids

by American College of RheumatologyCredit: CC0 Public DomainA new study reveals that Black patients with rheumatoid arthritis (RA) were less likely to be prescribed a biologic treatment and more

Updated on:July 02,2024 4

Warfarin use significantly increases risk of knee and hip replacement in people with OA

by American College of RheumatologyCredit: CC0 Public DomainNew research presented at ACR Convergence, the American College of Rheumatology's annual meeting, shows that use of warfarin, a vit

Updated on: May 23,2024 8

Warfarin use significantly increases risk of knee and hip replacement in people with OA

by American College of RheumatologyCredit: CC0 Public DomainNew research presented at ACR Convergence, the American College of Rheumatology's annual meeting, shows that use of warfarin, a vit

Updated on:May 23,2024 8

T-cells: The superheroes in the battle against omicron

by Luke O'neill,The ConversationCredit: AI-generated imageOmicron is spreading rapidly throughout the world, with experts claiming that 40% of the global population will be infected within t

Updated on: May 07,2024 11

T-cells: The superheroes in the battle against omicron

by Luke O'neill,The ConversationCredit: AI-generated imageOmicron is spreading rapidly throughout the world, with experts claiming that 40% of the global population will be infected within t

Updated on:May 07,2024 11

COVID infection may boost antibodies for up to 20 months

If you've already had COVID-19, your natural antibodies may last as long as 20 months, a new study suggests.While this is reassuring, experts are quick to caution that the new findings don't n

Updated on: April 13,2024 13

COVID infection may boost antibodies for up to 20 months

If you've already had COVID-19, your natural antibodies may last as long as 20 months, a new study suggests.While this is reassuring, experts are quick to caution that the new findings don't n

Updated on:April 13,2024 13

Minority patients with rheumatic diseases have worse COVID-19 outcomes

by American College of RheumatologyCredit: CC0 Public DomainNew research at ACR Convergence, the American College of Rheumatology's annual meeting, reveals that people of color with rheumatic

Updated on: May 29,2024 5

Minority patients with rheumatic diseases have worse COVID-19 outcomes

by American College of RheumatologyCredit: CC0 Public DomainNew research at ACR Convergence, the American College of Rheumatology's annual meeting, reveals that people of color with rheumatic

Updated on:May 29,2024 5

Study investigates rates of adverse events for common rheumatoid arthritis drug

by Brigham and Women's HospitalCredit: CC0 Public DomainMethotrexate is a common drug with a long history; for the past 40 years, it's been used to treat a range of diseases. Today it is

Updated on: June 17,2024 6

Study investigates rates of adverse events for common rheumatoid arthritis drug

by Brigham and Women's HospitalCredit: CC0 Public DomainMethotrexate is a common drug with a long history; for the past 40 years, it's been used to treat a range of diseases. Today it is

Updated on:June 17,2024 6